Kai Hong
Papers
1
Total Citations
3
H-Index
1
About
Dr. Kai Hong is a dedicated urologic oncology researcher whose work focuses on improving surgical outcomes for patients with renal cell carcinoma (RCC), particularly those with complex venous tumor thrombus (VTT). His major contribution lies in systematically identifying and analyzing risk factors for renal insufficiency following radical nephrectomy with thrombectomy—a high-stakes, gold-standard procedure for advanced RCC. By synthesizing evidence from multiple studies, Dr. Hong’s research provides critical insights into preserving postoperative kidney function, directly informing surgical decision-making and patient counseling. His 2025 systematic review has already garnered early citations, reflecting its timely relevance to the field. Dr. Hong’s work bridges a crucial gap between aggressive oncologic surgery and long-term renal health, making him a rising voice in urologic oncology. For students and researchers, his studies offer a clear roadmap for balancing cancer control with functional outcomes, underscoring the importance of evidence-based risk stratification in complex surgical oncology.
Research Focus
Key Achievements
Top Papers
- 1